PDCD1LG2 and neoplasm: Furthermore, 1,25(OH)2D has been shown to trigger tumor resistance by maintaining elevated PD-L1 and PD-L2 signaling in the tumor microenvironment, suppressing T cell-mediated anti-tumor immunity (33).